PT Pan Brothers Tbk (IDX:PBRX)

Intra-Cellular Therapies Ratios and Metrics

Market cap in millions IDR. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	451,123	494,087	1,074,101	699,656	997,658	1,593,661
Market Cap Growth	31.25%	-54.00%	53.52%	-29.87%	-37.40%	-51.77%
Enterprise Value	1,363,154	5,175,562	5,545,567	5,490,538	5,060,467	5,440,655
Last Close Price	21.00	23.00	50.00	74.48	106.20	169.64
PE Ratio	0.34	-	-	12.23	4.34	4.83
Forward PE	-	19.45	19.45	19.45	19.45	19.45
PS Ratio	0.10	0.10	0.12	0.07	0.10	0.17
PB Ratio	0.22	-0.25	0.21	0.13	0.24	0.41
P/TBV Ratio	0.19	-	0.20	0.13	0.24	0.42
P/FCF Ratio	28.81	-	-	4.22	-	-
P/OCF Ratio	8.80	-	-	3.27	-	-
PEG Ratio	-	0.57	0.57	0.57	0.57	0.57
EV/Sales Ratio	0.30	1.00	0.62	0.51	0.52	0.57
EV/EBITDA Ratio	-	-	10.40	7.80	6.55	6.16
EV/EBIT Ratio	-	-	14.47	10.33	8.66	7.74
EV/FCF Ratio	87.05	-	-	33.14	-	-
Debt / Equity Ratio	0.68	-2.78	0.98	1.01	1.08	1.12
Debt / EBITDA Ratio	-	-	9.01	7.40	5.67	4.80
Debt / FCF Ratio	88.95	-	-	32.40	-	-
Asset Turnover	1.01	0.67	0.82	0.97	0.99	1.01
Inventory Turnover	1.34	0.98	1.31	1.59	1.62	1.82
Quick Ratio	1.53	0.22	1.10	5.94	0.47	0.83
Current Ratio	4.48	0.53	3.37	16.28	1.49	2.47
Return on Equity (ROE)	700.89%	-429.03%	-1.29%	0.74%	5.39%	7.12%
Return on Assets (ROA)	-23.74%	-14.11%	2.19%	3.01%	3.69%	4.67%
Return on Capital (ROIC)	-29.63%	-15.38%	2.31%	3.31%	4.27%	5.40%
Return on Capital Employed (ROCE)	-	-	4.90%	5.00%	13.70%	11.00%
Earnings Yield	298.24%	-1460.64%	-1.75%	8.18%	23.05%	20.72%
FCF Yield	3.47%	-18.39%	-47.00%	23.68%	-11.13%	-35.64%
Buyback Yield / Dilution	-	-	-231.60%	-	-	-
Total Shareholder Return	-	-	-231.60%	-	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.